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Ventricular Premature Beats and 
Sympathetic Nerve Activity 
Welch et al. (1) reported that provoked ventricular premature beats 
led to bursts of efferent sympathetic discharge that had greater 
amplitude, duration and area than those that occur during sinus 
rhythm. Spontaneous (unprovoked) premature ventricular beats 
were also followed by unusually large bursts of sympathetic nerve 
activity. Postextrasystolic beats were followed by nearly complete 
neural silence. The concern they raised was that cardiac sympa- 
thetic activity may parallel discharge to the muscle sympathetic 
nerves in the leg and, if so, ventricular premature beats could 
modify cardiac sympathetic nerve activity and could be an impor- 
tant factor in the pathophysiology of sudden cardiac death in 
patients with heart failure. 
Is it appropriate to conclude from these studies in normal subjects 
that the neural response to ventricular ectopic beats is similar in 
patients with congestive heart failure? As demonstrated by Leimbach 
et al. (2). sympathetic traffic to muscle is markedly elevated in 
patients with congestive heart failure-in some patients, virtually all 
cardiac cycles are associated with a burst of sympathetic discharge. 
Patients with cirrhosis and ascites also display increased sympathetic 
discharge to muscle: in our own series, sympathetic activity appears 
to be higher in such patients than in patients with congestive heart 
failure. In one of these patients we had the opportunity to record the 
sympathetic neurogram during periods of spontaneous, closely cou- 
pled ventricular ectopic beats. As may be seen in Figure I, maximal 
burst amplitude was recorded during sinus rhythm and not after a 
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Figure 1. Tracing from a patient with very high sympathetic dis- 
charge. 
ventricular premature beat, ventricular ectopic beats did not consis- 
tently augment subsequent sympathetic discharge and there was no 
neural silence after postextrasystolic beats. These recordings, in a 
patient with extremely high sympathetic discharge, suggest that the 
observation made by Welch et al. (I) may be restricted to normal 
subjects. Do these authors have data on the effects of ventricular 
ectopic beats on sympathetic activity in patients with congestive 
heart failure and. if so, do they provide support for their concern? 
JOHN S. FLORAS, MD, FACC 
Division of Cardiolog! 
Department of Medicine 
Toronto General Hospital 
200 Elizabeth Street 
Toronto, Ontario. Canada MSG 2C4 
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Reply 
We appreciate Floras’s interest in our report. Five patients with 
heart disease were included in our study, and two of these had 
compensated congestive heart failure. Consistent with the observa- 
tions of Leimbach et al.. baseline sympathetic nerve activity in the 
patients with heart failure was increased (recordings from one of 
these patients constituted Figure 2 of our report). All of our 
subjects, including the two with heart failure. manifested increased 
sympathetic nerve activity after ventricular premature beats with 
coupling intervals 40% of the preceding RR interval, and mani- 
fested neural silence after corresponding postextrasystolic beats. 
The neural silence was frequently most apparent in the patients with 
heart failure because of the increased baseline activity. 
Floras’s recording from a patient with ascites is intriguing. 
Baseline sympathetic nerve activity is increased. There are two 
spontaneous ventricular premature beats. Consistent with our re- 
sults, the first premature beat appears to be followed by a sympa- 
thetic burst of increased duration and area. However, other features 
differ from our findings: the second premature beat does not appear 
to be followed by increased sympathetic activity, and neither 
postextrasystolic beat is followed by neural silence. 
There are several possible explanations for the differences 
between our results and Floras’s recording. First, his spontaneous 
premature beats are rather late coupled, occurring at approximately 
80% of the preceding RR interval. Our study suggested that a 
coupling interval of 80% lies near the threshold of prematurity 
required to provoke sympathetic changes, and that coupling inter- 
vals <60% are generally needed to provoke maximal changes. 
Second. his second premature beat fell just three beats after the first. 
Our study employed single premature beats provoked after 8 to IO 
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sinus beats and did not address sympathetic responses to more 
frequent or complex ectopic beats. Finally, it is possible that 
sympathetic responses vary among patient groups. Perhaps, when 
sympathetic drive is intense, it is difficult to either further increase 
or suppress sympathetic nerve activity. 
We thank Floras for sharing his recording and thoughts with us. 
Clearly, further study is needed to fully characterize sympathetic 
responses to cardiac arrhythmias. 
WILLIAM J. WELCH, MD 
MICHAEL L. SMITH. PHD 
ROBERT F. REA, MD 
ROBERT A. BAUERNFEIND, MD 
DWAIN L. ECKBERG. MD 
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What Is the Role of Vagal Tone in the 
Genesis of Life-Threatening Ventricular 
Tachyarrhythmias in Humans? 
Our recent clinical experience (1) is in agreement with the conclusions 
of Waxman et al. (2) in their study of the role of vagal tone in 
idioventricular rhythm, a benign ventricular arrhythmia. We (1) found 
that vagal tone may indeed play a substantial role even in life- 
threatening ventricular tachyarrhythmias in humans. At present, the 
effect of vagal activity on ventricular tachyarrhythmias is controver- 
sial. Although very limited clinical observations regarding the role of 
the vagus on ventricular instability are available, some data exist from 
experimental studies. In our experience (l), atropine administration 
(1 mg) in a stable patient and in the absence of acute myocardial 
ischemia induced a prolonged unusual dramatic ventricular rhythm 
necessitating direct current shock for termination. In particular. the 
rate of the arrhythmia was irregular and the QRS configuration varied 
continuously, which suggests that enhanced automaticity was prob- 
ably the arrhythmia mechanism. In patients with marked vagal 
overactivity, the immediate vagal tone removal may result in a 
parasympathetic-sympathetic imbalance; as a consequence, the mas- 
sive sympathetic activation may induce ventricular instability leading 
to this unusual ventricular tachyarrhythmia. We concluded that vagal 
tone per se may indeed be considered an important factor in the 
protection from malignant ventricular tachyarrhythmias in both ani- 
mals and humans. A major limitation of all the experimental studies 
indicating a protective vagal effect on ventricular instability is that 
they have been performed in anesthetized animals. However, recent 
experimental studies in conscious dogs (3) have confirmed that 
manipulations of the autonomic nervous system may indeed decrease 
susceptibility to ventricular fibrillation: our clinical experience and 
that of Waxman et al. (2) clearly support these experimental obser- 
vations. 
VINCENZO SANTINELLI, MD 
PIETRO TURCO. MD 
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In the case described by Santinelli et al., intravenous atropine 
induced polymorphic ventricular tachycardia. The tachycardia de- 
veloped before an increase in background atrial rate. Atrial pacing 
up to 110 beatsimin did not induce any arrhythmias. Thus it appears 
that the ventricular tachycardia was not secondary to a rise in atrial 
rate induced by atropine. In Figure 3 of the article by Santinelli et al. 
there is a considerable amount of ST segment depression in lead V, 
after restoration of sinus rhythm. This finding, coupled with the 
patient’s significant triple vessel coronary disease, raises the possi- 
bility that atropine induced myocardial ischemia, which in turn 
started the ventricular tachycardia. Atropine could induce myocar- 
dial ischemia by increasing the effects of background sympathetic 
tone on the heart secondary to blockade of muscarinic receptors in 
the region of sympathetic nerve terminals. 
Lazzari et al. (1) described the development of ventricular 
fibrillation after the intravenous administration of atropine to a 
patient with distal atrioventricular block. In that individual, there 
was no increase in heart rate before the onset of ventricular 
fibrillation. There was no clinical evidence of coronary artery 
disease and. during angiography, the left coronary artery was 
normal, but the right coronary artery could not be visualized. In 
Figure 3 of their report, the patient continued to have polymorphic 
ventricular tachycardia for 2 h after reversion of ventricular fibril- 
lation. Thus, whereas it seems clear that withdrawal of vagal tone by 
atropine can lead to ventricular tachycardia or ventricular fibrilla- 
tion without an increase in background heart rate, the mechanism 
underlying this reaction requires further exploration. 
MENASHE B. WAXMAN, MD 
Toronto General Hospital 
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Correction 
In Gillebert et al. (J Am Co11 Cardiol 1989;13:483-90), the 
first line of the abstract should read: To analyze the 
influence of loading patterns on cardiac pump perfor- 
mance and cardiac relaxation, the effects of preload on 
peak length-tension relation and of systolic load clamps 
on peak length-tension relation and on relaxation were 
analyzed in isolated cat papillary muscles. 
